News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Timothy Cannon, MD

Articles by Timothy Cannon, MD

Molecular Pathogenesis of Cholangiocarcinoma: Implications for Disease Classification and Therapy

ByKhaled W. Kabbara, MD,Timothy Cannon, MD,Arthur Winer, MD,Raymond C. Wadlow, MD

August 19th 2022

Khaled W. Kabbara, MD, and colleagues, research treatment options for cholangiocarcinoma.

Latest Updated Articles

Molecular Pathogenesis of Cholangiocarcinoma: Implications for Disease Classification and Therapy
Published: August 19th 2022 | Updated:

Trending on CancerNetwork

Neoadjuvant Pembrolizumab/Radiotherapy Earns EU Approval in HNSCC Group

Pembrolizumab/Belzutifan Improves DFS in ccRCC Following Nephrectomy

3 Things You Should Know About Single-Agent ADCs in TNBC Treatment

JSKN003 Receives FDA Fast Track Designation in Advanced PROC

ZEN-3694 Earns FDA Orphan Drug Designation in NUT Carcinoma

© 2025 MJH Life Sciences^®

All rights reserved.